Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aclasta to prevent bone loss after kidney transplantation
NCT01675089Phase 4Completed
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Jul 2012
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of zoledronic acid in renal osteodystrophy, sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Started Jul 2012; status: completed.
02
Drugs
zoledronic acid
03
Conditions
renal osteodystrophy
Beyond the preview
Go deeper on NCT01675089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01675089.